VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $197,108,000 | +50.0% | 8,481,433 | +2.7% | 0.01% | +33.3% |
Q1 2018 | $131,418,000 | -21.0% | 8,254,894 | +3.1% | 0.01% | -14.3% |
Q4 2017 | $166,387,000 | +52.1% | 8,007,068 | +4.9% | 0.01% | +40.0% |
Q3 2017 | $109,361,000 | -13.1% | 7,631,642 | +4.9% | 0.01% | -16.7% |
Q2 2017 | $125,853,000 | +63.5% | 7,274,717 | +4.2% | 0.01% | +50.0% |
Q1 2017 | $76,990,000 | -16.6% | 6,980,074 | +9.8% | 0.00% | -20.0% |
Q4 2016 | $92,325,000 | -38.2% | 6,358,456 | +4.5% | 0.01% | -44.4% |
Q3 2016 | $149,370,000 | +25.3% | 6,084,309 | +2.8% | 0.01% | +28.6% |
Q2 2016 | $119,175,000 | -14.3% | 5,917,325 | +11.9% | 0.01% | -22.2% |
Q1 2016 | $139,025,000 | -69.2% | 5,286,114 | +19.0% | 0.01% | -70.0% |
Q4 2015 | $451,403,000 | -38.4% | 4,440,755 | +8.0% | 0.03% | +11.1% |
Q3 2015 | $733,262,000 | -9.5% | 4,110,676 | +12.7% | 0.03% | -50.9% |
Q2 2015 | $810,157,000 | +26.0% | 3,646,892 | +12.7% | 0.06% | +25.0% |
Q1 2015 | $642,909,000 | +2584.0% | 3,236,883 | +1584.1% | 0.04% | +2100.0% |
Q4 2013 | $23,953,000 | – | 192,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |